More Business Wire
View Older Stories View Newer Stories-
Gorman-Rupp Completes Debt Refinancing
-
Acrisure Commences Tender Offer and Consent Solicitation
-
Silver Storm Adds Second Drill Rig and Commences Phase 2 Drill Program at La Parrilla
-
Arrowhead Pharmaceuticals Reports Successful Topline Results for Plozasiran from the Pivotal Phase 3 PALISADE Study in Patients with Familial Chylomicronemia Syndrome
-
Arcos Dorados to Participate in Upcoming Investor Event
-
Devonian Appoints André P. Boulet to Chairman of the Board and Chief Operating Officer
-
WM to Acquire Stericycle, a Leader in Medical Waste Services, for $7.2 Billion
-
Landmark Independent Publication in Nature Medicine Validates CareDx AlloView AI-Enabled Risk Prediction Model and Demonstrates AlloSure Kidney Detects Subclinical Rejection in Stable Patients
-
Newegg Announces New SaaS Multichannel Marketplace Management Solution -- SellingPilot
-
RadiusXR Achieves ISO 13485 and MDSAP Certifications, Announces Expansion into Canadian Market
-
SAIC Announces First Quarter of Fiscal Year 2025 Results
-
Calidi Biotherapeutics Presents CLD-101 Phase 1 Trial Update and Preclinical Data Highlighting RTNova and CLD-201 at 2024 ASCO Annual Meeting
-
Xeris Presents New Post Hoc Analysis on Effects of Levoketoconazole (Recorlev®) in Cushing’s Syndrome Patients at ENDO 2024
-
Pershing Square Holdings, Ltd. Notes the Sale by Pershing Square Capital Management, L.P. of a 10% Common Equity Interest to Strategic Investors
-
Quince Therapeutics Receives U.S. FDA Fast Track Designation for EryDex System
-
Flow Beverage Corp. to Release Second Quarter 2024 Financial Results
-
Consor Holdings Announces Growth Investment from New Mountain Capital
-
International Energy Forum Report Details EV Copper Hurdles
-
Bruker Launches Transformative neofleX™ MALDI-TOF System for Spatial Biology Mass Spec Imaging (MSI) Applications
-
Bausch + Lomb Launches Blink™ NutriTears® Clinically Proven Nutritional Supplement for Dry Eyes in the United States
-
Spruce Biosciences Presented Phase 2 POWER Study Results of Tildacerfont for the Treatment of Polycystic Ovary Syndrome at ENDO 2024
-
TriSalus Life Sciences Highlights Clinical Data from Phase 1b PERIO-02 Trial, Studying Delivery of Nelitolimod via Pressure-Enabled Drug Delivery in Patients with Hepatocellular Carcinoma or Intrahepa
-
IDRx Reports Updated Preliminary Phase 1 Data from Ongoing Phase 1/1b StrateGIST 1 Trial Supporting Best-in-Class Potential for IDRX-42 in Patients with GIST
-
Rockwell Automation to Advance Intelligent Automation, Mobile Robotics in Manufacturing Logistics in Collaboration with NVIDIA
-
ModernFi Announces Integration with Q2's Digital Banking Platform
-
Pershing Square Capital Management, L.P. Announces Sale of 10% Common Equity Interest for $1.05 Billion to Strategic Investors
-
BPGbio Appoints Biopharma Industry Leader Scott Minick to Board of Directors
-
Turing Medical Launches New Brain Mapping and Targeting Solution at ASSFN Biannual Meeting
-
D-Wave Quantum Featured in Fireside Chat at Needham Technology, Media and Consumer Conference
-
Former DOJ Section Chief and Big Law Partner Opens Solow, PLLC
-
Air Industries Group Reports Amendment to Loan Agreement with Webster Bank
-
Bicycle Therapeutics to Participate in Upcoming Investor Conferences
-
Bruker Launches Ultimate Sensitivity timsTOF Ultra 2 to Enable New Research Paradigms in Single-Cell and Subcellular Proteomics
-
Indiva Provides Update on SNDL Loan and Strategic Review
-
ProPetro Acquires Aqua Prop, an Innovative Wet Sand Solutions Provider
-
Innoviva to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
-
Bruker Applied Mass Spectrometry Division Showcases High-Performance Solutions for Research and Analysis in Applied Laboratories
-
Deciphera Pharmaceuticals Announces Oral Presentation of Results from MOTION Pivotal Phase 3 Study of Vimseltinib in Patients with Tenosynovial Giant Cell Tumor (TGCT) at the 2024 ASCO Annual Meeting
-
Greenbriar Equity Group Announces Acquisition of Renuity
-
Graham Corporation Receives $17 Million of Orders to Support Energy and Petrochemical Expansion Projects in North America and the Middle East
-
Network Perception Introduces Reporting as a Service Solution to Streamline NERC CIP and TSA Evidence Documentation
-
Mavenir, Qualcomm and EchoStar Achieve Industry-First 5G Open RAN RedCap Demonstration on the Boost Mobile Network
-
AECOM awarded U.S. nationwide program management services contract to support FEMA’s disaster resilience efforts
-
Leading Independent Proxy Advisory Firm ISS Recommends Vista Outdoor Stockholders Vote “FOR” the Sale of The Kinetic Group to CSG
-
Pinnacle West Announces Proposed Offering of $450 Million of Convertible Senior Notes Due 2027
-
Lindsay Announces Irrigation Project Valued at More Than $100 Million
-
Ward Dickson Appointed to Avery Dennison Board of Directors
-
Takeda’s TAK-861 Phase 2b Late-Breaking Data Presentations at SLEEP 2024 Demonstrate Clinically Meaningful Impact of Oral Orexin Agonist in Narcolepsy Type 1 Compared to Placebo
-
Kolibri Global Energy Inc. Announces Nickel Hill Production Rates and Inclusion in Russell Index
-
The Estée Lauder Companies Completes Acquisition of DECIEM
